Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jul 19, 2023
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the sounds we make when we talk—our vocal patterns—can help identify rare syndromes and congenital disorders. The main goal is to create a system that can automatically recognize these vocal patterns linked to specific conditions. Researchers will collect and analyze voice recordings to better understand how different syndromes affect speech.
To participate, individuals aged between 1 and 74 years old with a confirmed diagnosis of one of the studied syndromes can join, but they will need permission from a parent or legal representative if they are minors. Participants should be in good health and not have any recent upper respiratory infections. If you decide to take part, you'll be helping researchers develop new ways to diagnose and understand rare diseases through voice analysis, which could lead to better support for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Laboratory confirmation of the clinical diagnosis of one of the syndromes under investigation.
- • Informed consent from parents, legal representatives or the patients themselves, according to the instructions of the hospital's Ethics Committee.
- Exclusion Criteria:
- • Concomitant acute inflammatory disease of the upper respiratory tract.
- • Refusal to sign the informed consent to participate in the study.
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported